Everolimus Zentiva 10 mg Tabletten
Country: Switzerland
Language: German
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
everolimusum
Available from:
Helvepharm AG
ATC code:
L01XE10
INN (International Name):
everolimusum
Pharmaceutical form:
Tabletten
Composition:
everolimusum 10 mg, E 321, hypromellosum, lactosum 272 mg, lactosum monohydricum 25 mg, crospovidonum, magnesii stearas, pro compresso.
Class:
A
Therapeutic group:
Biotechnologika
Therapeutic area:
Brustkrebs, neuroendokrine Tumoren pankreatischen Ursprungs, neuroendokrine Tumoren gastrointestinalen oder pulmonalen Ursprungs, Nierenzellkarzinom
Authorization status:
zugelassen
Authorization date:
2021-05-20
